List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 407 studies with search of: gleevec
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Ph I Gleevec in Combo w RAD001 + Hydroxyurea for Pts w Recurrent MG
Conditions: Glioblastoma;   Gliosarcoma
Intervention: Drug: Gleevec, RAD001, and Hydroxyurea
2 Completed Zarnestra and Gleevec in Chronic Phase Chronic Myelogenous Leukemia
Condition: Leukemia, Myeloid, Chronic
Interventions: Drug: Zarnestra (R115777);   Drug: Gleevec (Imatinib mesylate)
3 Active, not recruiting Imatinib Mesylate (Gleevec) and Docetaxel in Patients With Head and Neck Squamous Cell Cancer
Conditions: Head and Neck Cancer;   Squamous Cell Cancer
Interventions: Drug: Imatinib Mesylate;   Drug: Docetaxel
4 Active, not recruiting Therapy of Early Chronic Phase CML With Gleevec
Condition: Leukemia, Myeloid, Chronic-Phase
Intervention: Drug: Gleevec
5 Active, not recruiting Preoperative and Postoperative Imatinib Mesylate Study in Patients With c-Kit Positive GIST
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: Imatinib Mesylate
6 Terminated Dose Escalation Study of Gleevec and Chlorambucil in Previously Treated Chronic Lymphocytic Leukemia Patients
Condition: Chronic Lymphocytic Leukemia
Intervention: Drug: Gleevec and Chlorambucil
7 Completed Use and Tolerability of Imatinib Mesylate (Gleevec) in Leukemia Patients
Condition: Leukemia
Intervention: Drug: Imatinib Mesylate
8 Completed A Study of Gleevec in Patients With Idiopathic Myelofibrosis or Chronic Myelomonocytic Leukemia (CMML)
Conditions: Myelofibrosis;   Myeloid Metaplasia;   Agnogenic Myeloid Metaplasia;   Chronic Myelomonocytic Leukemia
Intervention: Drug: Imatinib mesylate
9 Active, not recruiting Gleevec Study for Patients With Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: Imatinib Mesylate
10 Active, not recruiting Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma
Condition: Uterine Cancer
Interventions: Drug: Imatinib Mesylate;   Drug: Paclitaxel
11 Active, not recruiting Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma
Conditions: Solid Tumor;   Thyroid Cancer
Interventions: Drug: Capecitabine (Xeloda);   Drug: DTIC-Dome (Dacarbazine);   Drug: Gleevec (Imatinib Mesylate)
12 Recruiting Study of Gleevec and Weekly Paclitaxel in Patients Aged 70 or Older With Advanced Non-small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Intervention: Drug: Gleevec, paclitaxel
13 Recruiting Ph I Zactima + Imatinib Mesylate & Hydroxyurea for Pts w Recurrent MG
Conditions: Glioblastoma;   Gliosarcoma
Intervention: Drug: Zactima, Gleevec, Hydroxyurea
14 Completed Glivec® (Imatinib Mesylate, STI571) in Monotherapy Versus Glivec®-Interferon Alpha in the Treatment of Chronic-Phase Chronic Myeloid Leukaemia
Condition: Chronic Myeloid Leukaemia
Interventions: Drug: Glivec;   Drug: Interferon
15 Recruiting Study of Dose Escalation Versus no Dose Escalation of Imatinib in Metastatic Gastrointestinal Stromal Tumors (GIST) Patients
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: Imatinib mesylate
16 Recruiting Gleevec in Relapsed/Refractory T Cell Non-Hodgkin's Lymphoma
Condition: T Cell Non-Hodgkin Lymphoma
Intervention: Drug: Imatinib mesylate
17 Active, not recruiting Trial Evaluating Gleevec in Patients With Anaplastic Thyroid Carcinoma
Condition: Thyroid Cancer
Intervention: Drug: Imatinib (Gleevec)
18 Active, not recruiting Study of Temzolomide and Gleevec in Advanced Melanoma
Conditions: Melanoma;   Advanced Melanoma
Intervention: Drug: Gleevec + Temozolomide
19 Terminated Phase II Trial of Gleevec and Taxotere as a Combined Regimen for Advanced Gastric Adenocarcinoma
Condition: Gastric Adenocarcinoma
Intervention: Drug: Gleevec, Taxotere
20 Active, not recruiting Study Comparing 12 Months Versus 36 Months of Imatinib in the Treatment of Gastrointestinal Stromal Tumor (GIST)
Condition: Sarcoma
Interventions: Drug: imatinib mesylate;   Drug: imatinib

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services